This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Interventional, randomised, double-blind, parallel...
Clinical trial

Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose long-term study to evaluate the maintenance of efficacy and safety of 1 to 3 mg/day of brexpiprazole as adjunctive treatment in patients with major depressive diso

Read time: 1 mins
Last updated:3rd Apr 2013
Maintenance of efficacy during long-term treatment of brexpiprazole versus placebo as adjunctive treatment to antidepressants on depressive symptoms in patients with an insufficient response to antidepressant treatment
Category Value
Study start date 2013-04-03

View full details